Breaking: Major Growth Expected in the Biosimilar Contract...

Ajouter une nouvelle offre d'emploi Health

2026-07-01 06:32:56 -

Breaking: Major Growth Expected in the Biosimilar Contract Manufacturing Market

In an era where healthcare costs are skyrocketing, the significance of biosimilars in drug development has garnered tremendous attention. The global biosimilar contract manufacturing market is projected to witness exponential growth, with a remarkable increase from USD 7.73 billion in 2022 to an anticipated USD 51.9 billion by 2035. This represents a compound annual growth rate (CAGR) of...

0 Commentaires 0 Parts 75 Vue 0 Aperçu